NEWARK, New Jersey, November 1, 2021 / PRNewswire / – Newark Beth Israel Medical Center, a RWJBarnabas healthcare facility, has appointed David Seth Feldman, MD, PhD, FACC, FAHA, the new section chief for advanced heart failure treatment and transplantation.
Newark Beth Israel The Heart Failure Treatment and Transplant Program is one of the top 15 centers in the country and one of only 6% of centers in the country to have performed more than 1,100 heart transplants.
Dr. Feldman brings more than 25 years of in-depth research, innovation and clinical expertise to this accomplished team in the heart failure field. He will lead the advanced heart failure treatment and transplant program at Newark Beth Israel Medical Center and will also have satellite offices at Saint Barnabas Medical Center and Jersey City Medical Center.
âAfter conducting extensive national research, we are delighted to welcome Dr. Feldman to our team. We look forward to working together to improve our range of services and create better access for patients in the region in need of advanced therapies for heart failure and excellent cardiac care, âsaid Sergio waxman, MD, MBA, director of cardiology, Newark Beth Israel Medical Center.
“Newark Beth Israel Medical Center and Children’s Hospital of New Jersey is at the forefront of providing comprehensive cardiac care and innovative research. We are delighted to have Dr. Feldman join our team of experts who have dedicated themselves to creating a program that consistently delivers clinical excellence, âsaid Darrell K. Terry, Sr., MHA, MPH, FACHE, FHELA, President and CEO, Newark Beth Israel Medical Center and Children’s Hospital of New Jersey.
Dr. Feldman’s research and expertise focuses on the molecular mechanisms of heart failure, cardiogenic shock and heart transplantation. In addition, he has conducted research on mechanical circulatory support devices. He has contributed to cutting-edge research, published in national and international journals, which has contributed to the FDA approval of some of the most important mechanical support devices in use today. Her work has also helped establish national and international guidelines which, in part, set the global standard of care for every advanced myocardial therapy (heart failure and heart transplant) program in the world.
Dr. Feldman has also conducted extensive research on the disparities in heart care and the impact on African American communities. He is the author of numerous studies exploring the impact of race and socio-economic factors on blood pressure, atherosclerosis, and even willingness to adopt an exercise regimen.
Prior to joining Newark Beth Israel, Dr. Feldman was Director of Cardiovascular and Critical Care and Director of Advanced Myocardial and Circulatory Support at University of Cincinnati, where he worked with the team to improve overall survival rates for heart failure and heart transplant patients. He was also pivotal in establishing the nationally ranked Heart Failure and Heart Transplant Program at Abbott Northwestern Hospital, where he served as director from 2006 to 2009.
Dr Feldman is a member of the American Heart Association and the American College of Cardiology, and a member of the medical group of the Heart Failure Society of America and the International Society of Heart and Lung Transplant. He has received numerous awards, grants and accolades for his work in cardiovascular care and treatment, including being named to the lists of America’s Best Cardiologist and Best Physician.
About the Newark Beth Israel Heart Program
Newark Beth Israel Medical Center is home to one of the top 15 heart transplant centers in the country, with a strong heart failure and transplant section in the cardiovascular medicine division with more than seven providers. NBIMC Hosts from New Jersey only advanced lung disease and transplant program and mechanical circulatory support program that performs more VAD and ECMO than any other center in the state.
Newark Beth Israel Medical Center has always been at the forefront of cardiac care and heart transplantation. Dr. Victor Parsonnet performed the first heart transplant in New Jersey in establishment in 1986 and 1992, Newark Beth Israel became the premier center of New Jersey to use extracorporeal membrane oxygenation. Additionally, Newark Beth Israel was the first hospital to use left ventricular assist devices (LVADs) in New Jersey.
For more information on RWJBarnabas Health’s Heart Failure and Transplant Program, visit rwjbh.org/heart transplant.
About Newark Beth Israel Medical Center
Newark Beth Israel Medical Center, a RWJBarnabas health facility, is a 665-bed regional teaching hospital providing comprehensive health care. Newark Beth Israel is a leading teaching hospital and home to one of the top 15 heart transplant centers in the country, which has performed over 1,100 heart transplants; RWJBarnabas Health Heart Failure Treatment and Transplant Program; from New Jersey Only advanced lung disease and transplant program and valve center that performs complex heart valve procedures, including minimally invasive aortic valve catheter replacements (TAVRs). The Newark Beth Israel Medical Center is also home to the Children’s Hospital of New Jersey (CHoNJ), which takes care of children from birth to adolescence, with more than 30 specialized pediatric services including from New Jersey the largest children’s center of the Valerie Cancer and Blood Disorders Fund; and the Children’s Heart Center which offers a full range of medical and surgical treatments for the most complex heart abnormalities. Newark Beth Israel’s robotic surgery program is the most experienced in the north New Jersey. RWJBarnabas Health and The Frederick B. Cohen, MD, Comprehensive Cancer and Blood Disorders Center at Newark Beth Israel Medical Center and the Healthcare Foundation of New Jersey Breast Health Center, in partnership with Rutgers Cancer Institute of New Jersey – the state’s only NCI-designated cancer center – brings together a team of world-class researchers and specialists to fight alongside you, providing in-home access to the latest treatments and clinical trials. Newark Beth Israel Also offers many preventive health programs that promote wellness in the community, including The Beth Greenhouse, which provides access to fresh produce and health and wellness education to local residents.
Children’s hospital New Jersey (CHoNJ), located at Newark Beth Israel Medical Center, cares for children from birth to adolescence, with more than 30 specialized pediatric departments, including from New Jersey the largest children’s center of the Valerie Cancer and Blood Disorders Fund; and the Children’s Heart Center, which offers a full range of medical and surgical treatments for the most complex heart abnormalities. Children’s hospital New Jersey also includes a neonatal intensive care unit and a regional level IV perinatal center that offers from New Jersey extracorporeal oxygenation therapy only (ECMO); and the highest standard of intensive care for mothers and newborns.
View original content to download multimedia: https://www.prnewswire.com/news-releases/newark-beth-israel-medical-center-names-new-chief-of-advanced-heart-failure-treatment-and -transplant -301412973.html
SOURCE RWJBarnabas Health